MAPK/ERK Pathway

1,4-二氨基-2,3-二氰基-1,4-双(邻氨基苯巯基)丁二烯

U0126 (Synonyms: MEK1/2抑制剂 )

- 98+%

GDC-0879

GDC-0879

- 98+%

3-氨基-3-((4-氨基苯基)硫基)-2-(2-(三氟甲基)苯基)丙烯腈

SL 327

- 98+%

芝麻林素 | 芝麻灵

Sesamolin

- 98+%

沙尔威辛 | (±)-沙尔威辛

Salvicine

- 98+%

3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑

SD-06 | SD-0006

- 98+%

反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑

SB-239063

- 98+%

PD 169316

PD 169316

3-5days 98+%

TAK-715

TAK-715

- 98+%

GNE-9815

GNE-9815

- 98+%

柳杉酚 | 10-脱氧代黄桧醇

Sugiol | (+)-Sugiol | 10-Deoxoxanthoperol

- 98+%

司隆色替 | 瑟隆舍替

Selonsertib | GS-4997 | Selonsertib (free base)

- 98+%

SB 202190

SB 202190 | FHPI

- 98+%

2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺

PD184352(Synonyms: CI-1040)

3-5days 98+%

SX 011/SX-011

SX 011/SX-011

3-5days 98+%

维罗非尼

Vemurafenib (PLX 4032)

3-5days 98+%

2-(2,4-二氟苯基)-6-(1-(2,6-二氟苯基)脲基)烟酰胺

VX-702

- 98+%

(S)-(3,4-二氟-2-((2-氟-4-碘苯基)氨基)苯基)(3-羟基-3-(哌啶-2-基)氮杂环丁烷-1-基)甲酮;考比替尼

(S)-(3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone;Cobimetinib (GDC-0973; XL518)

In-stock 99+%; ee>99%

索拉非尼

Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base

In-stock 98+%

1-(3-(叔丁基)-1-(对甲苯基)-1H-吡唑-5-基)-3-(4-(2-吗啉乙氧基)萘-1-基)脲; 达马莫德；度马莫德

Doramapimod (Synonyms: BIRB 796)

- 98+%